Clinical Trial Update: Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine alone or in combination for inpatients with SARS-CoV-2/COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections
• Sars-cov-2

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Coronavirus Infections, SARS-CoV 2 | Phase 3 | Status: WITHDRAWN